ArticleNPJ primary care respiratory medicine2014
Trends in management and outcomes of COPD patients in primary care, 2000-2009: a retrospective cohort study.
Article in NPJ primary care respiratory medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.
- Effect of UK Quality and Outcomes Framework pay-for-performance programme on quality of primary care: systematic review with quantitative synthesis.BMJ (Clinical research ed.) · 2025Pooled it
- Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement.International journal of chronic obstructive pulmonary disease · 2023Pooled it
- Efficacy of Repeating Pulmonary Rehabilitation in People with COPD: A Systematic Review.International journal of chronic obstructive pulmonary disease · 2022Pooled it
- The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study.NPJ primary care respiratory medicine · 2016Trial
- Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.International journal of chronic obstructive pulmonary disease · 2016Trial
- Mortality in a Diverse, Real-World Lung Cancer Screening Cohort.Clinical lung cancer · 2025Observational
- Cumulative Dispensing of Oral Corticosteroids Over 12 Months in People with COPD.International journal of chronic obstructive pulmonary disease · 2025Article
- Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.Lancet regional health. Americas · 2023Article
- Are we missing lifetime COPD diagnosis among people with COPD recorded death? A population-based retrospective cohort study.BJGP open · 2022Article
- International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.American journal of respiratory and critical care medicine · 2022Review
- People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference study.ERJ open research · 2022Article
- Trends in non-receipt of recommended COPD medication.ERJ open research · 2022Article
- Article
- The stability of the ADO score among UK COPD patients from The Health Improvement Network.ERJ open research · 2020Article
- Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care.Thorax · 2019Article
- External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.International journal of chronic obstructive pulmonary disease · 2019Article
- A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management.International journal of chronic obstructive pulmonary disease · 2019Review
- Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD.Respiratory research · 2017Article
- Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.International journal of chronic obstructive pulmonary disease · 2017Review
- A year in the life of German patients with COPD: the DACCORD observational study.International journal of chronic obstructive pulmonary disease · 2016Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundSince the introduction of the Quality and Outcomes framework, there has been some evidence of improvement in the management of chronic obstructive pulmonary disease (COPD) patients in the United Kingdom through increasing rates of smoking cessation advice and immunisations against influenza. However, it is unknown whether disease-specific management criteria, disease outcomes and diagnosis have improved.
aimsTo describe changes in the management and outcomes of patients with COPD in UK general practice between 2000 and 2009.
methodsThe study was done on a retrospective cohort using data from The Health Improvement Network UK primary care database. We calculated age at diagnosis of COPD and death, total number of short-term oral corticosteroid courses and consultations, and proportion of patients with very severe COPD and on triple inhaled therapy for each year between 2000 and 2009.
resultsWe identified 92,576 patients with COPD. The mean age at COPD diagnosis decreased from 68.1 years in 2000 to 66.7 years in 2009. The mean age at death increased from 78.2 years in 2000 to 78.8 years in 2009. The number of prescribed courses of oral corticosteroids increased from 0.6 in 2000 to 0.8 in 2009. The number of consultations increased from 9.4 in 2004 to 11.3 in 2009. The risk of having very severe COPD decreased from 9.4% in 2004 to 6.8% in 2009. The likelihood of patients with very severe COPD receiving triple therapy increased from 25% in 2004 to 59% in 2009.
conclusionsThe trends suggest that management and outcomes observed in patients with COPD may have improved since the year 2000.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.